Second doctor described in new indictment against SAC's Martoma
NEW YORK Aug 22 (Reuters) - U.S. prosecutors on Thursday filed a superseding indictment in the insider trading case against a former portfolio manager at an affiliate of Steven A. Cohen's hedge fund SAC Capital Advisors, according to court papers.
The superseding indictment describes a second doctor who allegedly passed inside information to the former portfolio manager, Mathew Martoma, who was charged last November with insider trading in shares of the drug companies Elan and Wyeth, which is now a part of Pfizer.
Thursday's court filing said the doctor, described as "a co-conspirator," met with Martoma for paid consultations arranged through an expert networking firm and provided non-public information "with the expectation that Martoma would assist (the doctor) in obtaining additional clinical trial business."
- Scots independence polls close, UK's future in the balance |
- Islamic State shows captive British journalist in new video
- Australian PM says police raids follow IS linked beheading plot |
- New evacuations ordered as California wildfire doubles in size |
- Kurds issue call to arms as Islamic State gains in Syria